MM014

About Mucommune

Mucommune is a private, preclinical-stage biotech based in Cambridge, MA, and the Research Triangle, NC, with roots in academic research from Johns Hopkins and UNC. The company has evolved into a unique R&D engine, successfully spinning off Inhalon Biopharma, and now manages three core technology platforms: Elleon for female reproductive health, Polyon for polymer immunogenicity, and a stealth in vivo cell engineering platform for cancer and autoimmune diseases. Its strategy focuses on transforming early scientific discoveries into clinical-stage assets, supported by recent non-dilutive funding like an ARPA-H award for in vivo CAR-T development.

Therapeutic Areas